Monoclonal antibodies (mAbs) are lab-created antibodies that target specific disease molecules with high precision. A type of biologic therapy developed in 1975 by the scientists Köhler and Milstein, ...

Scientists can circumvent these challenges and keep their research moving forward with Bio X Cell’s in vivo antibodies, which are formulated in preservative-free PBS, tested for pathogens and ...

Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...

VIENNA — Nipocalimab, iscalimab, and tibulizumab, but not lusvertikimab, appear to be promising new agents for Sjögren disease that warrant further investigation, suggest the results of four separate ...

This article explores how advances in antibody engineering are moving immunotherapy beyond traditional monoclonal antibodies to bispecific and trispecific formats and logic-gated designs.

I n 2024, the U.S. Food and Drug Administration (FDA) approved the first monoclonal antibody for reducing food allergy reactions, including anaphylaxis, in adults and children age 1 year or older. The ...